Yingying Liang

Yingying Liang

Auto-generated profile, based on publicly available information

Yingying Liang

Lomonosov Moscow State University

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2026 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
AMAnna Monakova
Anna Monakova
NBNataliya Basalova
Nataliya Basalova
GSGeorgy Sagaradze
Georgy Sagaradze
ISI. V. Sharutin
I. V. Sharutin
YLYingying Liang
Yingying Liang
AEAnastasia Efimenko
Anastasia Efimenko
Aim . To create rat testicular cell collections characterized by pheno­types and functional activity to determine optimal conditions for their use in models for assessing the specific activity of spermatogenesis restoration drugs. Material and methods . To isolate different cell types from rat tes­tes, sequential enzymatic treatment of testicular tissue was used. Immu­no­cytochemical analysis of the isolated cell cultures was performed for canonical and non-canonical markers. Testosterone secretion by Leydig cells was measured on days 2, 4, and 7 of culture using enzyme-­linked immunosorbent assay. The developed model for assessing the biological activity of drugs in Leydig cells was validated in accordance with the requirements of the Eurasian Economic Commission Decision dated July 17, 2018, № 113. Results. The following cell cultures were isolated from rat testes and characterized: Leydig cells expressing specific CYP11A1 and LHR markers; resident mesenchymal stromal/stem cells expressing CD73, CD90, and PDGFRb markers; Sertoli cells expressing inhibin beta B and Sox9 markers; spermatogonial stem cells expressing GDNFR, c-kit, and alkaline phosphatase markers; and peritubular myoid cells expressing αSMA. It was shown that Leydig cells, when isolated in culture, began ex­pressing vinculin, and with prolonged cultivation and passaging, they acquired the Sox9 and vimentin markers. In addition, Leydig cells in culture sharply reduced their ability to secrete testosterone within a week. Based on these data, our previously developed in vitro mo­del for assessing the specific activity of drugs for spermatogenesis resto­ration was optimized and validated. Conclusion . The approaches used enable the formation of charac­te­rized collections of different cell types isolated from the testes of la­bo­ratory animals. However, when isolated from tissue, due to the loss of a specific microenvironment, the phenotypic and functional properties of the cells may change over time in culture. This should be taken into account when creating and subsequently using cell collections. A study was conducted on the phenotype of testicular cells, as well as the secretory activity of Leydig cells. Based on this, a method for asses­sing specific activity in vitro and an optimal biobanking strategy were de­veloped.

17 October 2026 in Acta Biomedica Scientifica
Verified
Journal Article
Open access
PDF file
AMA. O. Mnatsakanyan
A. O. Mnatsakanyan
NBNataliya Basalova
Nataliya Basalova
GSGeorgy Sagaradze
Georgy Sagaradze
LYLiang Yingying
Liang Yingying
NNN. V. Nagibin
N. V. Nagibin
АЕА. Ю. Ефименко
А. Ю. Ефименко
Background. Previously, it has been shown in animal models that the secretome of mesenchymal stromal cells (MSCs) can restore the spermatogonial stem cell niche. In a mouse model of doxorubicin-induced toxic damage to spermatogenesis, it was shown that the biodistribution of MSC secretome following administration under the tunica albuginea of the testis occurs mainly in the interstitium, which consists predominantly of Leydig cells. However, the effect of MSC secretome on Leydig cells under doxorubicin-induced damage remains unexplored. Aim. To study the effect of MSC secretome on Leydig cells under doxorubicin-induced damage in vitro and in vivo. Materials and Methods. Spermatogenesis damage was modeled in C57Bl/6 mice, which received intraperitoneal injections of doxorubicin at a total dose of 10 mg/kg. Three groups of animals were studied: intact, damaged, and MSC secretome-treated. For in vitro studies, doxorubicin (at concentrations ranging from 0.15 to 1.5 µM) and MSC secretome were added to Leydig cell cultures. Results. Following doxorubicin-induced damage in vivo, mouse testis weight decreased and did not recover after MSC secretome injection. The interstitial area increased upon damage, while administration of MSC secretome tended to reduce (normalize) the interstitial area. At the same time, the number of Leydig cells did not change significantly. In in vitro studies, exposure of Leydig cells to doxorubicin induced dose-dependent cell death. Addition of MSC secretome to Leydig cells under damage conditions enhanced cell survival and testosterone secretion, resulting in an increase in total testosterone content in the Leydig cell culture medium. Conclusion. MSC secretome can act on Leydig cells under doxorubicin-induced damage by increasing their number and secretory activity, which may contribute to interstitial recovery. These findings provide a rationale for further investigation of MSC secretome as a promising therapeutic agent for restoring testicular function.